Literature DB >> 22346401

Antibiotic and oral contraceptive drug interactions: Is there a need for concern?

G G Zhanel1, S Siemens, K Slayter, L Mandell.   

Abstract

OBJECTIVE: To assess the clinical significant of antibiotic and oral contraceptive drug interactions. DATA SELECTION: MEDLINE search from 1975 to 1998 (September) inclusive. Search terms 'antitiobic', 'oral contraceptive' and 'pregnancy' were included. Published papers as well as references from these papers were reviewed. Papers documenting mechanistic interactions between antibiotics and oral contraceptives were included. DATA EXTRACTION: Studies reporting oral contraceptive pharmacokinetics, mechanisms, incidence, implicated antibiotics and clinical consequences of antibiotic/oral contraceptive drug interactions. DATA SYNTHESIS: Reports of oral contraceptive failure seem to be most numerous in women using preparations containing 30 μg of ethinylestradiol and 150 μ g of levonorgestrel. Rifampin is the only antibiotic that has been reported to reduce plasma estrogen concentrations. When taking rifampin, oral contraceptives cannot be relied upon and a second method of contraception is mandatory. Amoxicillin, ampicillin, griseofulvin, metronidazole and tetracycline have been associated with contraceptive failure in three or more clinical cases. When these agents are used, the clinician should discuss the available data with the patient and suggest a second form of birth control. Other antibiotics are most likely safe to use concomitantly with oral contraceptives.
CONCLUSIONS: Rifampin is the only antibiotic to date that has been reported to reduce plasma estrogen concentrations. Oral contraceptives cannot be relied upon for birth control while taking rifampin.

Entities:  

Keywords:  Antibiotics; Drug interactions; Oral contraceptives; Pregnancy

Year:  1999        PMID: 22346401      PMCID: PMC3250726          DOI: 10.1155/1999/539376

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  25 in total

1.  Pill method failures.

Authors:  M J Sparrow
Journal:  N Z Med J       Date:  1987-02-25

2.  Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics.

Authors:  D J Back; S F Grimmer; M L Orme; C Proudlove; R D Mann; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

3.  The effect of ampicillin administration on urinary estriol and serum estradiol in the normal pregnant patient.

Authors:  F H Boehm; D L DiPietro; D A Goss
Journal:  Am J Obstet Gynecol       Date:  1974-05-01       Impact factor: 8.661

4.  Possible interactions of antihistamines and antibiotics with oral contraceptive effectiveness.

Authors:  E A DeSano; S C Hurley
Journal:  Fertil Steril       Date:  1982-06       Impact factor: 7.329

Review 5.  Norgestimate: a clinical overview of a new progestin.

Authors:  J Bringer
Journal:  Am J Obstet Gynecol       Date:  1992-06       Impact factor: 8.661

Review 6.  Rifampin drug interactions.

Authors:  A M Baciewicz; T H Self
Journal:  Arch Intern Med       Date:  1984-08

Review 7.  Oral contraceptive drug interactions: important considerations.

Authors:  A Fazio
Journal:  South Med J       Date:  1991-08       Impact factor: 0.954

8.  The effect of tetracycline on levels of oral contraceptives.

Authors:  A A Murphy; H A Zacur; P Charache; R T Burkman
Journal:  Am J Obstet Gynecol       Date:  1991-01       Impact factor: 8.661

9.  The effects of ampicillin on oral contraceptive steroids in women.

Authors:  D J Back; A M Breckenridge; M MacIver; M Orme; P H Rowe; C Staiger; E Thomas; J Tjia
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

10.  The effect of ampicillin on oral contraceptive effectiveness.

Authors:  C I Friedman; A L Huneke; M H Kim; J Powell
Journal:  Obstet Gynecol       Date:  1980-01       Impact factor: 7.661

View more
  6 in total

1.  Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials.

Authors:  Peter Dogterom; Michiel W van den Heuvel; Torben Thomsen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.

Authors:  George G Zhanel; Jenine Esquivel; Sheryl Zelenitsky; Courtney K Lawrence; Heather J Adam; Alyssa Golden; Rachel Hink; Liam Berry; Frank Schweizer; Michael A Zhanel; Denice Bay; Philippe R S Lagacé-Wiens; Andrew J Walkty; Joseph P Lynch; James A Karlowsky
Journal:  Drugs       Date:  2020-02       Impact factor: 9.546

Review 3.  Non-surgical management of recurrent urinary tract infections in women.

Authors:  Paul A Bergamin; Anthony J Kiosoglous
Journal:  Transl Androl Urol       Date:  2017-07

Review 4.  A review of diagnosis and treatment of acne in adult female patients.

Authors:  A U Tan; B J Schlosser; A S Paller
Journal:  Int J Womens Dermatol       Date:  2017-12-23

5.  In vitro metabolic profile and drug-drug interaction assessment of secnidazole, a high-dose 5-nitroimidazole antibiotic for the treatment of bacterial vaginosis.

Authors:  Helen S Pentikis; Nikki Adetoro; Gregory Kaufman
Journal:  Pharmacol Res Perspect       Date:  2020-08

Review 6.  The Development of Third-Generation Tetracycline Antibiotics and New Perspectives.

Authors:  Aura Rusu; Emanuela Lorena Buta
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.